Award
National Institute of Allergy and Infectious Diseases 5R44AI140708-07
A Vaccine for Lymphatic Filariasis, LFGuard™
Recipient
Not Specified
Award Amount
$713,883.00
Ceiling
$713,883.00
Awarded
May 19, 2026
Identifier
5R44AI140708-07
Award for developing a prophylactic vaccine for lymphatic filariasis, involving regulatory and preclinical activities, managed by NIH/NIAID.
Description
The project aims to develop a prophylactic vaccine for lymphatic filariasis. The project includes activities for regulatory submission, preclinical testing, and IND submission. It involves a multivalent recombinant fusion protein vaccine (LFguard™). The award is managed by the NIH/NIAID and is scheduled from December 2025 to November 2026 for budget, with the overall project ending in November 2027.